 MALVERN, Pa., Oct. 06, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. Ocugen or the Company NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company will present at two important conferences this month. 